glp-1 news today october 9 2025 Perspectives from employers on the costs and issues associated with covering agonists for weight loss GLP-1 Weight-Loss Drug Demonstration Begins

This distribution suggests GIP influences metabolism through somewhat different pathways than GLP-1, even though both are incretin hormones

GLP-1 Injection Weight Loss Program (Oral GLP-1 treatment options may be considered based on eligibility) Semaglutide and Liraglutide are GLP-1 medications administered by subcutaneous injection to support long-term weight loss

Kathleen Valenton, board certified doctor and Lemme Medical Advisory Board member

Availability is subject to change

Since some adverse effects such as serious infections and skin cancers were reported, additional evaluation of the safety profile of this drug is needed (Gordon 2012